AVIJF yields 2.02% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, AVIJF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AVIJF + PFE for your $10,000?
AviChina Industry & Technology Company Limited engages in the research, development, manufacture, and sale of civil aviation products and related engineering services. It operates through three segments: Aviation Entire Aircraft Business, Aviation Ancillary System and Related Business, and Aviation Engineering Services Business. The company is involved in the development, manufacture, sale, and upgradation of defense and civil aviation products, such as helicopters, trainer and general-purpose aircrafts, and regional jets; and manufacture and sale of aviation ancillary system products, including connectors, avionics products, and its accessories. It also offers component products, including optical and electrical interconnection components and assemblies, cable assemblies, system interconnection equipment, fluid devices and equipment, etc., that are used in aviation, aerospace and other military fields, communications and data transmission, and new energy vehicles, as well as rail civil high-end manufacturing fields, such as transportation, consumer electronics, industry, energy, medical care, and intelligent equipment. In addition, the company provides various aviation power supply systems, fire extinguishing systems, environmental control systems, engine ignition systems and accessories, etc. Further, it offers aviation engineering services, such as planning, design, consultation, construction services. The company was incorporated in 2003 and is based in Beijing, the People's Republic of China. AviChina Industry & Technology Company Limited is a subsidiary of Aviation Industry Corporation of China, Ltd.
Full AVIJF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.